Partial Deletion Of Y
Last Posted: Sep 24, 2019
- Genetic abnormalities in a large cohort of Coffin-Siris syndrome patients.
Sekiguchi Futoshi, et al. Journal of human genetics 2019 9
- Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition.
Gambale Antonella, et al. Clinical genetics 2019 7
- Copy number variants detection by microarray and multiplex ligation-dependent probe amplification in congenital heart diseases.
Nagy Orsolya, et al. Journal of biotechnology 2019 5
- Evidence for the involvement of the proximal copy of the MAGEA9 gene in Xq28-linked CNV67 specific to spermatogenic failure.
Shen Ying, et al. Biology of reproduction 2017 2
- Analysis of partial azoospermia factor c deletion and DAZ copy number in azoospermia and severe oligozoospermia.
Alimardanian L, et al. Andrologia 2016 11 (9) 890-894
- Gene copy number alterations in the azoospermia-associated AZFc region and their effect on spermatogenic impairment.
Lu Chuncheng, et al. Molecular human reproduction 2014 9 (9) 836-43
- Common AZFc structure may possess the optimal spermatogenesis efficiency relative to the rearranged structures mediated by non-allele homologous recombination.
Yang Bo, et al. Scientific reports 2015 0 10551
- Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy.
Pasmant E, et al. Neuro-Chirurgie 2015 6
- Genetic Risk of Azoospermia Factor (AZF) Microdeletions in Idiopathic Cases of Azoospermia and Oligozoospermia in Central Indian Population.
Ambulkar Prafulla S, et al. Journal of clinical and diagnostic research : JCDR 2014 3 (3) 88-91
- Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation.
Martis S, et al. The pharmacogenomics journal 2013 12 (6) 558-66
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.